These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19536567)

  • 21. Interaction of C20-substituted derivative of pregnenolone acetate with copper (II) leads to ROS generation, DNA cleavage and apoptosis in cervical cancer cells: Therapeutic potential of copper chelation for cancer treatment.
    Zafar A; Singh S; Ahmad S; Khan S; Imran Siddiqi M; Naseem I
    Bioorg Chem; 2019 Jun; 87():276-290. PubMed ID: 30908970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic activity, X-ray crystal structures and spectroscopic characterization of cobalt(II), copper(II) and zinc(II) coordination compounds with 2-substituted benzimidazoles.
    Sánchez-Guadarrama O; López-Sandoval H; Sánchez-Bartéz F; Gracia-Mora I; Höpfl H; Barba-Behrens N
    J Inorg Biochem; 2009 Sep; 103(9):1204-13. PubMed ID: 19628280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel silver iodide metalo-drug: experimental and computational modelling assessment of its interaction with intracellular DNA, lipoxygenase and glutathione.
    Banti CN; Kyros L; Geromichalos GD; Kourkoumelis N; Kubicki M; Hadjikakou SK
    Eur J Med Chem; 2014 Apr; 77():388-99. PubMed ID: 24681027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone.
    Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR
    Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cu(II), Ni(II) complexes derived from chiral Schiff-base ligands: Synthesis, characterization, cytotoxicity, protein and DNA-binding properties.
    Li Z; Yan H; Chang G; Hong M; Dou J; Niu M
    J Photochem Photobiol B; 2016 Oct; 163():403-12. PubMed ID: 27619741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New mononuclear and binuclear oxomolybdenum(V) complexes containing NN chelator: Syntheses, DFT calculations, interaction with BSA protein and in vitro cytotoxic activity.
    Roy M; Biswal D; Sarkar O; Pramanik NR; Drew MGB; Sadhukhan P; Kundu M; Sil PC; Chakrabarti S
    J Inorg Biochem; 2019 Oct; 199():110755. PubMed ID: 31299376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ruthenium(II) carbonyl complexes containing S-methylisothiosemicarbazone based tetradentate ligand: synthesis, characterization and biological applications.
    Selvamurugan S; Ramachandran R; Viswanathamurthi P
    Biometals; 2013 Oct; 26(5):741-53. PubMed ID: 23780567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectroscopy, electrochemistry and antiproliferative properties of Au(iii), Pt(ii) and Cu(ii) complexes bearing modified 2,2':6',2''-terpyridine ligands.
    Maroń A; Czerwińska K; Machura B; Raposo L; Roma-Rodrigues C; Fernandes AR; Małecki JG; Szlapa-Kula A; Kula S; Krompiec S
    Dalton Trans; 2018 May; 47(18):6444-6463. PubMed ID: 29688241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New dinuclear palladium(II) complexes with benzodiazines as bridging ligands: interactions with CT-DNA and BSA, and cytotoxic activity.
    Franich AA; Živković MD; Ćoćić D; Petrović B; Milovanović M; Arsenijević A; Milovanović J; Arsenijević D; Stojanović B; Djuran MI; Rajković S
    J Biol Inorg Chem; 2019 Oct; 24(7):1009-1022. PubMed ID: 31385067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary anti-cancer photodynamic therapeutic in vitro studies with mixed-metal binuclear ruthenium(II)-vanadium(IV) complexes.
    Holder AA; Taylor P; Magnusen AR; Moffett ET; Meyer K; Hong Y; Ramsdale SE; Gordon M; Stubbs J; Seymour LA; Acharya D; Weber RT; Smith PF; Dismukes GC; Ji P; Menocal L; Bai F; Williams JL; Cropek DM; Jarrett WL
    Dalton Trans; 2013 Sep; 42(33):11881-99. PubMed ID: 23783642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molybdenocene-oligonucleotide binding study at physiological pH using NMR spectroscopy and cyclic voltammetry.
    Vera JL; Román FR; Meléndez E
    Bioorg Med Chem; 2006 Dec; 14(24):8683-91. PubMed ID: 16945539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
    Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA
    Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and characterisation of thiosemicarbazonato molybdenum(VI) complexes and their in vitro antitumor activity.
    Vrdoljak V; Dilović I; Rubcić M; Kraljević Pavelić S; Kralj M; Matković-Calogović D; Piantanida I; Novak P; Rozman A; Cindrić M
    Eur J Med Chem; 2010 Jan; 45(1):38-48. PubMed ID: 19815314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, characterization, photoluminescence, anti-tumor activity, DFT calculations and molecular docking with proteins of zinc(ii) halogen substituted terpyridine compounds.
    Liang X; Jiang J; Xue X; Huang L; Ding X; Nong D; Chen H; Pan L; Ma Z
    Dalton Trans; 2019 Jul; 48(28):10488-10504. PubMed ID: 31210199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph₂PCH₂S(O)xPh (x = 0-2) ligands.
    Ludwig G; Mijatović S; Ranđelović I; Bulatović M; Miljković D; Maksimović-Ivanić D; Korb M; Lang H; Steinborn D; Kaluđerović GN
    Eur J Med Chem; 2013 Nov; 69():216-22. PubMed ID: 24042044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrolytic metal with a hydrophobic periphery: titanium(IV) complexes of naphthalene-2,3-diolate and interactions with serum albumin.
    Tinoco AD; Eames EV; Incarvito CD; Valentine AM
    Inorg Chem; 2008 Sep; 47(18):8380-90. PubMed ID: 18710217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and cytotoxic activities of organometallic Ru(II) diamine complexes.
    Kavukcu SB; Şahin O; Seda Vatansever H; Kurt FO; Korkmaz M; Kendirci R; Pelit L; Türkmen H
    Bioorg Chem; 2020 Jun; 99():103793. PubMed ID: 32278205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Copper(II) complexes with highly water-soluble L- and D-proline-thiosemicarbazone conjugates as potential inhibitors of Topoisomerase IIα.
    Bacher F; Enyedy É; Nagy NV; Rockenbauer A; Bognár GM; Trondl R; Novak MS; Klapproth E; Kiss T; Arion VB
    Inorg Chem; 2013 Aug; 52(15):8895-908. PubMed ID: 23829568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ruthenium(II) sulfoxide-maltolato and -nitroimidazole complexes: synthesis and MTT assay.
    Wu A; Kennedy DC; Patrick BO; James BR
    Inorg Chem; 2003 Nov; 42(23):7579-86. PubMed ID: 14606854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New titanocene derivative with improved stability and binding ability to albumin exhibits high anticancer activity.
    Serrano R; Martinez-Argudo I; Fernandez-Sanchez M; Pacheco-Liñan PJ; Bravo I; Cohen B; Calero R; Ruiz MJ
    J Inorg Biochem; 2021 Oct; 223():111562. PubMed ID: 34364140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.